164093292	164093292	CD	B-NP	O
|	|	NNP	I-NP	O
WHOC	WHOC	NNP	I-NP	O
|	|	VBD	B-VP	O
09360461	09360461	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5186721	5186721	CD	B-NP	O
|	|	CC	I-NP	O
1/9/2006	1/9/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
ICD	ICD	NN	I-NP	O
implant	implant	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/29/2006	2/29/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/17/2006	3/17/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
LOGUIDICE	LOGUIDICE	NN	B-NP	O
,	,	,	O	O
RAMON	RAMON	NN	B-NP	O
228-03-04-8	228-03-04-8	CD	I-NP	O
Car	Car	NNP	I-NP	O
Sti	Sti	NNP	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/12/06	2/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VONGKHAMCHANH	VONGKHAMCHANH	NNP	B-NP	O
,	,	,	O	O
ANTON	ANTON	NNP	B-NP	O
BOYD	BOYD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/10	11/10	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
resume	resume	VB	B-VP	O
immediately	immediately	RB	B-ADVP	O
upon	upon	IN	B-PP	O
d/c	d/c	NN	B-NP	O
home	home	NN	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/12/06	2/12/06	CD	B-NP	O
by	by	IN	B-PP	O
HULSLANDER	HULSLANDER	NN	B-NP	O
,	,	,	O	O
ZACHARY	ZACHARY	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TORADOL	TORADOL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
424277010	424277010	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
KETOROLAC	KETOROLAC	NNP	I-NP	O
TROMETHAMINE	TROMETHAMINE	NNP	I-NP	O
,	,	,	O	O
INJ	INJ	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-ADJP	O
currently	currently	RB	B-ADVP	O
off	off	IN	B-PP	O
plavix	plavix	NN	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
CAVIGGIA	CAVIGGIA	NN	B-NP	O
,	,	,	O	O
EDWARDO	EDWARDO	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NIASPAN	NIASPAN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
459860777	459860777	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
-	-	HYPH	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

COREG	COREG	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CARVEDILOL	CARVEDILOL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
KEFLEX	KEFLEX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
CEPHALEXIN	CEPHALEXIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
250	250	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QID	QID	NN	I-NP	O
X	X	SYM	B-VP	O
28	28	CD	B-NP	O
doses	dose	NNS	I-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
PLAVIX	PLAVIX	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Saturday	Saturday	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/12	9/12	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/12/06	2/12/06	CD	B-NP	O
by	by	IN	B-PP	O
RAPIN	RAPIN	NN	B-NP	B-protein
,	,	,	O	O
GLEN	GLEN	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TORADOL	TORADOL	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
424277010	424277010	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLOPIDOGREL	CLOPIDOGREL	NNP	B-NP	O
BISULFATE	BISULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
KETOROLAC	KETOROLAC	NNP	I-NP	O
TROMETHAMINE	TROMETHAMINE	NNP	I-NP	O
,	,	,	O	O
INJ	INJ	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-ADJP	O
currently	currently	RB	B-ADVP	O
off	off	IN	B-PP	O
plavix	plavix	NN	B-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/10	11/10	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
BUNDETTE	BUNDETTE	NN	B-NP	O
,	,	,	O	O
RYAN	RYAN	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALDACTONE	ALDACTONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
292942003	292942003	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
-	-	HYPH	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

NIASPAN	NIASPAN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NICOTINIC	NICOTINIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
PENTTILA	PENTTILA	NNP	B-NP	O
,	,	,	O	O
LANNY	LANNY	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
-	-	HYPH	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	IN	B-PP	O
5-10	5-10	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
PAXIL	PAXIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PAROXETINE	PAROXETINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ALDACTONE	ALDACTONE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
TINGER	TINGER	NN	B-NP	B-protein
,	,	,	O	O
GARFIELD	GARFIELD	NN	B-NP	O
POTENTIALLY	POTENTIALLY	NN	I-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
-	-	HYPH	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
x1	x1	NN	I-NP	O
Starting	Start	VBG	B-VP	O
Tomorrow	Tomorrow	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
11/10	11/10	CD	I-NP	I-protein
-RRB-	-RRB-	NNPS	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
follow	follow	VB	B-VP	O
previous	previous	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/12/06	2/12/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
per	per	IN	B-PP	O
previous	previous	JJ	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting/lifting	lifting/lifting	NN	I-NP	O
right	right	JJ	I-NP	O
arm	arm	NN	I-NP	O
above	above	IN	B-PP	O
head	head	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
Lift	Lift	NN	I-NP	O
restrictions	restriction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
lift	lift	VB	I-VP	O
greater	great	JJR	B-NP	O
then	then	RB	B-ADVP	O
5-10	5-10	CD	B-NP	O
pounds	pound	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Augustus	Augustus	NNP	I-NP	O
Kwong	Kwong	NNP	I-NP	O
7/22/06	7/22/06	CD	I-NP	O
9	9	CD	I-NP	O
AM	AM	NN	I-NP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/4/06	2/4/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3-4	3-4	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
cardilogist	cardilogist	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ICD	ICD	NN	I-NP	O
implant	implant	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PPM/AICD	PPM/AICD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
implanted	implant	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
defibrillator	defibrillator	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
AVR	AVR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
stent	stent	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stent	stent	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LBBB	LBBB	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CRT-D	CRT-D	NNP	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
EP	EP	NN	B-NP	O
lab	lab	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
64	64	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
valvular	valvular	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
s/p	s/p	NN	I-NP	O
mechanical	mechanical	JJ	I-NP	O
AVR	AVR	NN	I-NP	O
and	and	CC	I-NP	O
CAD/MI	CAD/MI	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
PCIs	PCI	NNS	I-NP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
LBBB	LBBB	NN	B-NP	B-protein
morphology	morphology	NN	I-NP	O
on	on	IN	B-PP	O
ECG	ECG	NN	B-NP	B-protein
.	.	.	O	O

CRT-D	CRT-D	NN	B-NP	O
device	device	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
10/4	10/4	CD	B-NP	O
Subsequent	Subsequent	JJ	I-NP	O
pocket	pocket	NN	I-NP	O
infection	infection	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
E	E	NN	I-NP	O
coli	coli	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
prompting	prompt	VBG	B-VP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
admitted	admit	VBN	B-ADJP	O
for	for	IN	B-PP	O
reimplantation	reimplantation	NN	B-NP	O
of	of	IN	B-PP	O
CRT-D	CRT-D	NN	B-NP	O
device	device	NN	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
procedure	procedure	NN	I-NP	O
today	today	NN	B-NP	O
:	:	:	O	O
Guidant	Guidant	NNP	B-NP	O
Contak	Contak	NNP	I-NP	O
Renewal	Renewal	NNP	I-NP	O
.	.	.	O	O

Leads	Lead	NNS	B-NP	O
in	in	IN	B-PP	O
RV	RV	NN	B-NP	O
apex	apex	NN	I-NP	O
,	,	,	O	O
RAA	RAA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CS	CS	NN	B-NP	O
.	.	.	O	O

DDD	DDD	NN	B-NP	O
40	40	CD	I-NP	O
-	-	:	O	O
120	120	CD	B-NP	O
.	.	.	O	O

Access	Access	NN	B-NP	O
via	via	IN	B-PP	O
R	R	NN	B-NP	O
cephalic	cephalic	JJ	I-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	O
axillary	axillary	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

pCXR	pCXR	NN	B-NP	O
ok	ok	NN	I-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	B-protein
attending	attend	VBG	B-VP	O
will	will	MD	B-VP	O
defer	defer	VB	I-VP	O
anticoagulation	anticoagulation	NN	B-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
.	.	.	O	O

5/25/06	5/25/06	LS	B-LST	O
:	:	:	O	O
pt	pt	NN	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADJP	O
overnight	overnight	JJ	I-ADJP	O
.	.	.	O	O

c/o	c/o	NN	B-NP	B-protein
mild-moderate	mild-moderate	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
at	at	IN	B-PP	O
wound	wound	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

mild	mild	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
gross	gross	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

VS	VS	NN	B-NP	O
,	,	,	O	O
tele	tele	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
CXR	CXR	NN	B-NP	B-protein
reviewed	review	VBN	B-VP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
saturday	saturday	NN	B-NP	O
.	.	.	O	O

coumadin	coumadin	NN	B-NP	O
resumed	resume	VBD	B-VP	O
tomorrow	tomorrow	NN	B-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
resumed	resume	VBD	B-VP	O
today	today	NN	B-NP	O
.	.	.	O	O

f/u	f/u	SYM	O	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
dr	dr	NN	B-NP	O
nims	nim	NNS	I-NP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
.	.	.	O	O

have	have	VB	B-VP	O
INR	INR	NN	B-NP	B-protein
checked	check	VBD	B-VP	O
in	in	IN	B-PP	O
3-4	3-4	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
have	have	VBP	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
level	level	NN	I-NP	O
checked	check	VBD	B-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Radabaugh	Radabaugh	NNP	I-NP	O
3-4	3-4	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
resuming	resume	VBG	B-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
may	may	MD	B-VP	O
resume	resume	VB	I-VP	O
your	your	PRP$	B-NP	O
plavix	plavix	NN	I-NP	O
on	on	IN	B-PP	O
saturday	saturday	NN	B-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
resume	resume	VBP	B-VP	O
taking	take	VBG	I-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
-RRB-	-RRB-	SYM	O	O
tonight	tonight	NN	B-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
get	get	VBP	B-VP	O
home	home	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
may	may	MD	B-VP	O
resume	resume	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
tomorrow	tomorrow	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Thursday	Thursday	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PAPCIAK	PAPCIAK	NN	B-NP	O
,	,	,	O	O
DUDLEY	DUDLEY	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
BX40	BX40	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2/12/06	2/12/06	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

